Jump to main content
Jump to site search

Issue 9, 2019
Previous Article Next Article

Simultaneous detection of multiple NT-proBNP clinical samples utilizing an aptamer-based sandwich assay on an integrated microfluidic system

Author affiliations

Abstract

Although cardiovascular diseases such as heart failure (HF) affect 30 million people globally, the early detection of HF has, until recently, been difficult and prone to misdiagnoses. Monitoring the circulatory levels of a relatively new biomarker, the N-terminal prohormone of a B-type natriuretic peptide, could be used for early risk evaluation of HF. Therefore, we developed a pneumatically-driven, automatic integrated microfluidic platform equipped with micromixers, micropumps, and microvalves for the simultaneous detection of NT-proBNP in up to six clinical samples within 25 min by using a novel aptamer-based sandwich assay, and the limit of detection was only 1.53 pg mL−1; given that the chip is 64% more compact than those developed in our prior works and requires only 5 μL of sample input, it may serve as a promising tool for early diagnosis of HF.

Graphical abstract: Simultaneous detection of multiple NT-proBNP clinical samples utilizing an aptamer-based sandwich assay on an integrated microfluidic system

Back to tab navigation

Supplementary files

Article information


Submitted
03 Feb 2019
Accepted
22 Mar 2019
First published
25 Mar 2019

Lab Chip, 2019,19, 1676-1685
Article type
Paper

Simultaneous detection of multiple NT-proBNP clinical samples utilizing an aptamer-based sandwich assay on an integrated microfluidic system

A. Sinha, P. Gopinathan, Y. Chung, S. Shiesh and G. Lee, Lab Chip, 2019, 19, 1676
DOI: 10.1039/C9LC00115H

Social activity

Search articles by author

Spotlight

Advertisements